Product Information
BUDESONIDE DR 3 MG CAPSULE is a generic product labeled by Padagis US LLC, priced at $0.5134 per EA under NDC 00574985510. Its NADAC has been published 412 times since Aug 8, 2018.
Strength
3 mg/1
Manufacturer
Padagis US LLCNDC
00574985510
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUDESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA021324On Market Since
6/29/2018
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE DR 3 MG CAPSULE has been published 412 times since Aug 8, 2018, and over the history we have for it it has declined 85.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5134 per EA |
|---|---|
| All-time high | $3.5382 (Sep 12, 2018) |
| All-time low | $0.4242 (Nov 20, 2024) |
| 52-week high | $0.5280 |
| 52-week low | $0.5024 |
| Median price | $0.7837 |
| Average price | $1.0499 |
| Largest weekly change | -35.6% (Apr 22, 2020) |
| Weeks tracked | 412 |
| Tracking since | Aug 8, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUDESONIDE DR 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE DR 3 MG CAPSULE, manufactured by Padagis US LLC, is $0.5134 per EA (NDC 00574985510), effective Jun 24, 2026.
How has the price of BUDESONIDE DR 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUDESONIDE DR 3 MG CAPSULE has declined 85.3%. It has been tracked across 412 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE DR 3 MG CAPSULE?
Since Aug 8, 2018, the NADAC for BUDESONIDE DR 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $3.5382 (Sep 12, 2018), with a median of $0.7837 per EA.
Are there cheaper alternatives to BUDESONIDE DR 3 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BUDESONIDE DR 3 MG CAPSULE, but none are currently priced below it.
Who manufactures BUDESONIDE DR 3 MG CAPSULE?
BUDESONIDE DR 3 MG CAPSULE (NDC 00574985510) is labeled by Padagis US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification